|
Sign In to gain access to subscriptions and/or personal tools.
|
Pulmonary hemorrhage in systemic lupus erythematosus
LA Barile
Rheumatic Disease Unit, Hospital de Especialidades, Centro Médico La Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico
LJ Jara
Rheumatic Disease Unit, Hospital de Especialidades, Centro Médico La Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico
F. Medina-Rodriguez
Rheumatic Disease Unit, Hospital de Especialidades, Centro Médico La Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico
JL Garcia-Figueroa
Rheumatic Disease Unit, Hospital de Especialidades, Centro Médico La Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico
JM Miranda-Limón
Rheumatic Disease Unit, Hospital de Especialidades, Centro Médico La Raza, Instituto Mexicano del Seguro Social, Mexico City, Mexico
In order to assess the clinical characteristics and survival rate of pulmonary hemorrhage (PH) in systemic lupus erythematosus (SLE), we studied SLE patients who developed this complication. We found 34 patients within a total lupus cohort of 630 patients.
A11 the patients had severe respiratory failure. We identified three different treatment regimens: (a) oral prednisone (1 mg/kg); (b) conventional methylprednisolone (3 g total dose) and (c) massive methylprednisolone ( > 4 g).
The overall survival rate was 38.2% and it was correlated with the massive regimen and early treatment (within the first 48 h after the onset of the acute event).
Key Words: pulmonary hemorrhage systemic lupus erythematosus therapeutic trial
Lupus, Vol. 6, No. 5,
445-448 (1997)
DOI: 10.1177/096120339700600506

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Todd and K. Costenbader
Dyspnoea in a young woman with active systemic lupus erythematosus
Lupus,
August 1, 2009;
18(9):
777 - 784.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. K. Derebail, P. Parikh, J. C. Jennette, and A. V. Kshirsagar
A rare cause of the pulmonary-renal syndrome: a case of atypical haemolytic-uraemic syndrome complicated by pulmonary haemorrhage
NDT Plus,
December 1, 2008;
1(6):
417 - 419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Rojas-Serrano, J Pedroza, J Regalado, J Robledo, E Reyes, J Sifuentes-Osornio, and L. Flores-Suarez
High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage
Lupus,
April 1, 2008;
17(4):
295 - 299.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Swigris, A. Fischer, J. Gilles, R. T. Meehan, and K. K. Brown
Pulmonary and Thrombotic Manifestations of Systemic Lupus Erythematosus
Chest,
January 1, 2008;
133(1):
271 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.M. Bertoli, L.M. Vila, M. Apte, B.J. Fessler, H.M. Bastian, J.D. Reveille, and G.S. Alarcon
Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage
Lupus,
June 1, 2007;
16(6):
410 - 417.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M A Garcia, J C Marcos, A I Marcos, B A Pons-Estel, D Wojdyla, A Arturi, J C Babini, L J Catoggio, and D Alarcon-Segovia
Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients
Lupus,
December 1, 2005;
14(12):
938 - 946.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
W W Chatham and R P Kimberly
Treatment of lupus with corticosteroids
Lupus,
March 1, 2001;
10(3):
140 - 147.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Santos-Ocampo, B. F. Mandell, and B. J. Fessler
Alveolar Hemorrhage in Systemic Lupus Erythematosus : Presentation and Management
Chest,
October 1, 2000;
118(4):
1083 - 1090.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|